| Literature DB >> 31557164 |
KaLynn Harlow1, Christina R Ferreira2, Tiago J P Sobreira2, Theresa Casey1, Kara Stewart1.
Abstract
We hypothesized that postnatal development of the vagina is impacted by early nutritional environment. Our objective was to determine if lipid profiles of vaginal swabs were different between postnatal gilts suckled by sow or fed milk replacer the first 48 h after birth, with or without a lard-based fat supplement. Gilts (>1.3 kg) were selected at birth across 8 litters and assigned to one of four treatments: 1) suckled by sow (S, n = 8); 2) suckled by sow plus administration of a fat supplement (SF, n = 5); 3) bottle-fed solely milk replacer (B, n = 8); or 4) bottle-fed solely milk replacer plus administration of a fat supplement (BF, n = 7). At 48 h postnatal, vaginal swabs of gilts were taken with a cytology brush, and lipids were extracted for analysis using multiple reaction monitoring (MRM)-profiling. Lipids extracted from serum collected at 48 h from gilts, milk collected at 24 h from sows, and milk replacer were also analyzed with MRM-profiling. Receiver operating characteristic curve analysis found 18 lipids recovered from vaginal swabs that highly distinguished between S and B gilts [area-under-the-curve (AUC) > 0.9], including phosphatidylethanolamine with 34 carbons and four unsaturations in the fatty acyl residues [PE (34:4)]. Twelve lipids from vaginal swabs highly correlated (r > 0.6; p < 0.01) with nutrition source. Lipids with greater abundance in milk replacer drove association. For example, mean intensity of PE (34:4) was 149-fold higher in milk replacer than colostrum. Consequently, PE (34:4) was found to have 1.6- and 2.12-fold higher levels in serum and vaginal swab samples (p < 0.001), respectively, of B gilts as compared to S gilts. Findings support that vaginal swabs can be used to noninvasively study effects of perinatal nutrition on tissue composition.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31557164 PMCID: PMC6762109 DOI: 10.1371/journal.pone.0215186
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Birthright™ milk replacer analysis and ingredients.
| Crude protein, (min) | 24% |
| Crude fat, (min) | 18% |
| Crude fiber, (max) | 0.15%. |
| Calcium, minimum | 0.85% |
| Calcium, maximum | 0.95% |
| Phosphorus, minimum | 0.7% |
| Vitamin A, (min) | 30,000 IU/lb |
| Vitamin D3, (min) | 4,000 IU/lb |
| Vitamin E, (min) | 120 IU/lb |
Fig 1MRM lipid class distribution.
Lipid class distribution of MRMs: (A) detected in initial discovery phase; (B) Selected for method 1; and (C) Selected for method 2.
Fig 2Principal component analysis and heatmaps for respective methods.
(A) Principal component analysis and (B) heat map of lipids selected for Method 1; within the hierarchical analysis, red signifies bottle-fed animals (B and BF) and green signifies suckled animals (S and SF). (C) Principal component analysis and (D) heat map of lipids selected for Method 2; within the hierarchical analysis, red signifies fat supplemented (SF and BF) and green signifies not supplemented (S and B) animals. In the heatmap, blue indicates lower ion intensities and red indicates higher ion intensities. MRMs are on the right and animal ID is on the bottom.
Fig 3Mean ion intensity of selected MRMs.
Mean ion intensity of precursor-product ion MRMs of (A) cholesteryl ester 425.4->369; (B) ceramide 557.4->282.2; (C) glycerolipid containing eicosapentaenoic acid residue 631.2->283.9; and (D) glycerolipid containing eicosapentaenoic acid residue 780.2->432.9 measure in lipid extracts of vaginal swabs taken from bottle fed (B), bottle fed and fat supplemented (BF), suckled by sow (S) and suckled by sow plus fat supplemented (SF) for 48 h postnatal. Differing letters indicate statistical difference at p<0.05; and (*) indicates an overall fat supplement treatment effect.
Pearson correlation coefficients of 38 MRMs with highest AUC values.
| Serum vs Nutrition Source | Serum vs Swab | Swab vs Nutrition Source | |||||
|---|---|---|---|---|---|---|---|
| MRM ID | Tentative ID Attribution | ||||||
| 442.4–59.1 | hydroxy octadecanoyl carnitine | -0.15 | 0.56 | 0.36 | 0.16 | -0.43 | 0.09 |
| 514.5–131.2 | Not identified | -0.04 | 0.89 | 0.12 | 0.67 | -0.22 | 0.42 |
| 640.4–339.1 | Not identified | 0.15 | 0.58 | -0.29 | 0.26 | 0.09 | 0.73 |
| 678.6–184.2 | PC(28:0)/PS(28:1) | 0.28 | 0.28 | 0.13 | 0.63 | ||
| 712.5–495.2 | PE(34:4) | ||||||
| 738.5–521.2 | PE(36:5) | 0.43 | 0.09 | ||||
| 739.6–522.3 | PG(34:6) | 0.28 | 0.29 | ||||
| 766.5–521.2 | TAG(44:1) | 0.39 | 0.13 | ||||
| 766.5–549.2 | PE(38:5) | 0.42 | 0.11 | ||||
| 768.4–495.1 | TAG(44:0) | 0.27 | 0.32 | ||||
| 768.5–523.2 | TAG(44:0) | 0.11 | 0.71 | ||||
| 776.1–184.2 | PC(36:7) | 0.14 | 0.59 | 0.13 | 0.62 | ||
| 793.7–520.4 | Not identified | 0.25 | 0.34 | ||||
| 794.5–521.2 | TAG(46:1) | 0.38 | 0.14 | ||||
| 794.5–549.2 | TAG(46:1) | 0.42 | 0.11 | ||||
| 818.8–519.8 | TAG(48:3) | 0.43 | 0.09 | 0.42 | 0.11 | ||
| 820.7–521.4 | TAG(48:2) | 0.32 | 0.22 | 0.32 | 0.23 | 0.36 | 0.17 |
| 822.8–521.8 | TAG(48:1) | -0.26 | 0.32 | 0.22 | 0.42 | -0.15 | 0.57 |
| 400.4–101.1 | Not identified | 0.06 | 0.81 | 0.22 | 0.42 | 0.13 | 0.62 |
| 428.4–85.1 | Stearoylcarnitine, hexadecanedioic acid mono-L-carnitine ester | -0.12 | 0.65 | 0.07 | 0.78 | ||
| 476.5–177.2 | Not identified | 0.26 | 0.32 | 0.04 | 0.87 | -0.19 | 0.48 |
| 638.5–339.2 | Not identified | -0.11 | 0.69 | -0.39 | 0.13 | -0.31 | 0.24 |
| 640.29–340.99 | Not identified | 0.35 | 0.18 | -0.03 | 0.91 | 0.43 | 0.1 |
| 706.7–184.2 | PC(30:0)/PS(30:1) | 0.43 | 0.09 | ||||
| 766.5–495.2 | TAG(44:1) | 0.42 | 0.11 | 0.14 | 0.61 | ||
| 767.1–549.8 | TAG(44:1) | -0.07 | 0.78 | ||||
| 774.5–184.2 | PC(36:8)/PE(38:1) | 0.34 | 0.19 | 0.11 | 0.68 | ||
| 775.8–184.2 | PG(36:2)/PI(30:4) | 0.11 | 0.67 | -0.02 | 0.93 | ||
| 792.5–521.2 | TAG(46:2) | -0.45 | 0.08 | 0.11 | 0.69 | -0.16 | 0.53 |
| 795.5–550.2 | TAG(48:6)/PG(38:6) | 0.11 | 0.69 | 0.22 | 0.42 | ||
| 796.1–522.8 | Not identified | 0.29 | 0.27 | 214 | 0.67 | 0.15 | 0.58 |
| 796.5–579.2 | TAG(46:0) | 0.45 | 0.07 | -0.007 | 0.97 | 0.31 | 0.23 |
| 808.6–509.3 | PC(38:5) | 0.26 | 0.34 | -0.01 | 0.95 | 0.25 | 0.35 |
| 818.8–521.8 | TAG(48:3) | 0.26 | 0.32 | -0.23 | 0.41 | ||
Bold values indicate either r > |0.60| or P-value < 0.01.
Fig 4Comparison of relative mean intensity of selected MRMs between respective sources.
Comparison of relative mean intensity of PE (34:4), 712.5->495.19 in (A) nutrition source (24 h colostrum sample versus milk replacer-MR); (B) serum of suckled-S versus bottle fed milk replacer-B; and (C) vaginal swab samples in S versus B gilts. Relative mean intensity of PE (36:5), 738.5->521.19 in (D) nutrition source (24 h colostrum sample versus milk replacer-MR); (E) serum of suckled-S versus bottle fed milk replacer-B; and (F) vaginal swab samples in S versus B gilts. Relative mean intensity of PG (34:6), 739.6->522.29 in (G) nutrition source (24 h colostrum sample versus milk replacer-MR); (H) serum of suckled-S versus bottle fed milk replacer-B; and (I) vaginal swab samples in S versus B gilts. Differing letters indicate statistical difference at p<0.005.